Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ram Mishra

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Living Beings

Physiology

Concepts & Ideas

Structure-Activity Relationship

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
34
Johnson, Rodney
11
Nair, Venugopalan
9
Skoblenick, Kevin
7
Gabriele, Joseph
7
Chong, Victor
7
Costain, Willard
7
Ross, Gregory
6
Thomas, Nancy
6
Ojala, William
6
Castellano, Jessica
6
Gleason, WB
5
Pontoriero, Giuseppe
5
Pradhan, A
4
Dyck, Bailee
3
Dolbeare, Kristine

Sign-in to see all Coauthors

Publications

TOP 3
Gabriele Joseph; Pontoriero Giuseppe F; Thomas Nancy; Thomson Christy A; Skoblenick Kevin; Pristupa Zdenek B; Mishra Ram K
Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders.
Dyck Bailee A; Skoblenick Kevin J; Castellano Jessica M; Ki Kitty; Thomas Nancy; Mishra Ram K
Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia.
Raghavan Bhooma; Skoblenick Kevin J; Bhagwanth Swapna; Argintaru Niran; Mishra Ram K; Johnson Rodney L
Allosteric modulation of the dopamine D2 receptor by Pro-Leu-Gly-NH2 peptidomimetics constrained in either a polyproline II helix or a type II beta-turn conformation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ram Mishra (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gabriele Joseph; Pontoriero Giuseppe F; Thomas Nancy; Thomson Christy A; Skoblenick Kevin; Pristupa Zdenek B; Mishra Ram K
Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders.
Cell stress & chaperones 2009;14(6):555-67.
2009: Dyck Bailee A; Skoblenick Kevin J; Castellano Jessica M; Ki Kitty; Thomas Nancy; Mishra Ram K
Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia.
Synapse (New York, N.Y.) 2009;63(8):662-72.
2009: Raghavan Bhooma; Skoblenick Kevin J; Bhagwanth Swapna; Argintaru Niran; Mishra Ram K; Johnson Rodney L
Allosteric modulation of the dopamine D2 receptor by Pro-Leu-Gly-NH2 peptidomimetics constrained in either a polyproline II helix or a type II beta-turn conformation.
Journal of medicinal chemistry 2009;52(7):2043-51.
2007: Vartak Ashish P; Skoblenick Kevin; Thomas Nancy; Mishra Ram K; Johnson Rodney L
Allosteric modulation of the dopamine receptor by conformationally constrained type VI beta-turn peptidomimetics of Pro-Leu-Gly-NH2.
Journal of medicinal chemistry 2007;50(26):6725-9.
2007: Dyck Bailee A; Skoblenick Kevin J; Castellano Jessica M; Ki Kitty; Thomas Nancy; Mishra Ram K
Synapsin II knockout mice show sensorimotor gating and behavioural abnormalities similar to those in the phencyclidine-induced preclinical animal model of schizophrenia.
Schizophrenia research 2007;97(1-3):292-3.
2007: Castellano Jessica M; Batrynchuk Jody; Dolbeare Kristine; Verma Vaneeta; Mann Amandeep; Skoblenick Kevin J; Johnson Rodney L; Mishra Ram K
MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats.
Peptides 2007;28(10):2009-15.
2006: Skoblenick K J; Castellano J M; Rogoza R M; Dyck B A; Thomas N; Gabriele J P; Chong V Z; Mishra R K
Translocation of AIF in the human and rat striatum following protracted haloperidol, but not clozapine treatment.
Apoptosis : an international journal on programmed cell death 2006;11(5):663-72.
2006: Sondhi S; Castellano J M; Chong V Z; Rogoza R M; Skoblenick K J; Dyck B A; Gabriele J; Thomas N; Ki K; Pristupa Z B; Singh A N; MacCrimmon D; Voruganti P; Foster J; Mishra R K
cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects.
The pharmacogenomics journal 2006;6(2):131-40.
2006: Fisher Abigail; Mann Amandeep; Verma Vaneeta; Thomas Nancy; Mishra Ram K; Johnson Rodney L
Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor.
Journal of medicinal chemistry 2006;49(1):307-17.
2006: Chong V Z; Skoblenick K; Morin F; Xu Y; Mishra R K
Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.
Neuroscience 2006;138(2):587-99.
2005: Verma Vaneeta; Mann Amandeep; Costain Willard; Pontoriero Giuseppe; Castellano Jessica M; Skoblenick Kevin; Gupta Suresh K; Pristupa Zdenek; Niznik Hyman B; Johnson Rodney L; Nair Venugopalan D; Mishra Ram K
Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog.
The Journal of pharmacology and experimental therapeutics 2005;315(3):1228-36.
2005: Gabriele Joseph P; Chong Victor Z; Pontoriero Giuseppe F; Mishra Ram K
Decreased expression of a 40-kDa catecholamine-regulated protein in the ventral striatum of schizophrenic brain specimens from the Stanley Foundation Neuropathology Consortium.
Schizophrenia research 2005;74(1):111-9.
2004: Rogoza Raina M; Fairfax David F; Henry Paul; N-Marandi Sevil; Khan Rao F; Gupta Suresh K; Mishra Ram K
Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Synapse (New York, N.Y.) 2004;54(3):156-63.
2004: Chong V Z; Costain W; Marriott J; Sindwani S; Knauer D J; Wang J-F; Young L T; MacCrimmon D; Mishra R K
Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment.
The pharmacogenomics journal 2004;4(6):379-87.
2003: Dolbeare Kristine; Pontoriero Giuseppe F; Gupta Suresh K; Mishra Ram K; Johnson Rodney L
Iso-lactam and reduced amide analogues of the peptidomimetic dopamine receptor modulator 3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide.
Bioorganic & medicinal chemistry 2003;11(18):4103-12.
2003: Sharma S; Paladino P; Gabriele J; Saeedi H; Henry P; Chang M; Mishra R K; Johnson R L
Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia.
Peptides 2003;24(2):313-9.
2003: Dolbeare Kristine; Pontoriero Giuseppe F; Gupta Suresh K; Mishra Ram K; Johnson Rodney L
Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of L-prolyl-L-leucyl-glycinamide.
Journal of medicinal chemistry 2003;46(5):727-33.
2003: Singh Amarendra N; Barlas Cia; Saeedi Huma; Mishra Ram K
Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.
Journal of psychiatry & neuroscience : JPN 2003;28(1):39-47.
2003: Costain Willard J; Mishra Ram K
PLG regulates hnRNP-L expression in the rat striatum and pre-frontal cortex: identification by ddPCR.
Peptides 2003;24(1):137-46.
2003: Sharan Niki; Chong Victor Z; Nair Venugopalan D; Mishra Ram K; Hayes Robert J; Gardner Eliot L
Cocaine treatment increases expression of a 40 kDa catecholamine-regulated protein in discrete brain regions.
Synapse (New York, N.Y.) 2003;47(1):33-44.
2002: Gabriele Joseph; Rajaram Mahesh; Zhang Bingjun; Sharma Sunjay; Mishra Ram K
Modulation of a 40-kDa catecholamine-regulated protein following D-amphetamine treatment in discrete brain regions.
European journal of pharmacology 2002;453(1):13-9.
2002: Chong Victor Z; Young L Trevor; Mishra Ram K
cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment.
Journal of neurochemistry 2002;82(6):1533-9.
2002: Zhang Bingjun; van Adel B A; Gabriele Joseph; Duong Mike; Henry Paul; Ball A K; Mishra R K
Expression of the 40 kDa catecholamine regulated protein in the normal and injured rat retina.
Journal of chemical neuroanatomy 2002;24(1):41-8.
2001: Chiu S; Singh A N; Chiu P; Mishra R K
Inverse agonist binding of peripheral benzodiazepine receptors in anxiety disorder.
European archives of psychiatry and clinical neuroscience 2001;251(3):136-40.
2001: Marcotte E R; Chugh A; Barlas C; Mishra R K
Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57 BL/6 mice.
Neuroscience letters 2001;306(1-2):21-4.
2001: Goto A; Doering L; Nair V D; Mishra R K
Immunohistochemical localization of a 40-kDa catecholamine regulated protein in the nigrostriatal pathway.
Brain research 2001;900(2):314-9.
2001: Nair V D; Mishra R K
Molecular cloning, localization and characterization of a 40-kDa catecholamine-regulated protein.
Journal of neurochemistry 2001;76(4):1142-52.
2001: Sharan N; Nair V D; Mishra R K
Modulation of a 40-kDa catecholamine regulated protein by dopamine receptor antagonists.
European journal of pharmacology 2001;413(1):73-9.
2000: Ott M C; Costain W J; Mishra R K; Johnson R L
L-prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3(R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum.
Peptides 2000;21(2):301-8.
1999: Baures P W; Pradhan A; Ojala W H; Gleason W B; Mishra R K; Johnson R L
Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of L-prolyl-L-leucyl-glycinamide (PLG).
Bioorganic & medicinal chemistry letters 1999;9(16):2349-52.
1999: Mishra R K; Makman M H; Costain W J; Nair V D; Johnson R L
Modulation of agonist stimulated adenylyl cyclase and GTPase activity by L-pro-L-leu-glycinamide and its peptidomimetic analogue in rat striatal membranes.
Neuroscience letters 1999;269(1):21-4.
1999: Khalil E M; Pradhan A; Ojala W H; Gleason W B; Mishra R K; Johnson R L
Synthesis and dopamine receptor modulating activity of substituted bicyclic thiazolidine lactam peptidomimetics of L-prolyl-L-leucyl-glycinamide.
Journal of medicinal chemistry 1999;42(15):2977-87.
1999: Evans M C; Pradhan A; Venkatraman S; Ojala W H; Gleason W B; Mishra R K; Johnson R L
Synthesis and dopamine receptor modulating activity of novel peptidomimetics of L-prolyl-L-leucyl-glycinamide featuring alpha,alpha-disubstituted amino acids.
Journal of medicinal chemistry 1999;42(8):1441-7.
1999: Khalil E M; Ojala W H; Pradhan A; Nair V D; Gleason W B; Mishra R K; Johnson R L
Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide.
Journal of medicinal chemistry 1999;42(4):628-37.
1999: Costain W J; Buckley A T; Evans M C; Mishra R K; Johnson R L
Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats.
Peptides 1999;20(6):761-7.
1998: Nair V D; Savelli J E; Mishra R K
Modulation of dopamine D2 receptor expression by an NMDA receptor antagonist in rat brain.
Journal of molecular neuroscience : MN 1998;11(2):121-6.
1998: Marcotte E R; Chugh A; Mishra R K; Johnson R L
Protection against MPTP treatment by an analog of Pro-Leu-Gly-NH2 (PLG, MIF-1)
Peptides 1998;19(2):403-6.
1997: Baures P W; Ojala W H; Costain W J; Ott M C; Pradhan A; Gleason W B; Mishra R K; Johnson R L
Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide.
Journal of medicinal chemistry 1997;40(22):3594-600.
1997: Mishra R K; Marcotte E R; Chugh A; Barlas C; Whan D; Johnson R L
Modulation of dopamine receptor agonist-induced rotational behavior in 6-OHDA-lesioned rats by a peptidomimetic analogue of Pro-Leu-Gly-NH2 (PLG).
Peptides 1997;18(8):1209-15.
1996: Nair V D; Niznik H B; Mishra R K
NMDA and dopamine D2L receptor interaction in human neuroblastoma SH-SY5Y cells involves tyrosine kinase and phosphatase.
Neuroreport 1996;7(18):2937-40.
1996: Ott M C; Mishra R K; Johnson R L
Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
Brain research 1996;737(1-2):287-91.
1996: Nair V D; Niznik H B; Mishra R K
Interaction of NMDA and dopamine D2L receptors in human neuroblastoma SH-SY5Y cells.
Journal of neurochemistry 1996;66(6):2390-3.
1996: Modi P I; Kashyap A; Nair V D; Ross G M; Fu M; Savelli J E; Marcotte E R; Barlas C; Mishra R K
Modulation of brain catecholamine absorbing proteins by dopaminergic agents.
European journal of pharmacology 1996;299(1-3):213-20.
1995: Ross G M; McCarry B E; Mishra R K
Covalent affinity labeling of brain catecholamine-absorbing proteins using a high-specific-activity substituted tetrahydronaphthalene.
Journal of neurochemistry 1995;65(6):2783-9.
1995: Savelli J E; Chugh A; Cheng C; Mishra R K; Johnson R L
Modulation of N-methyl-D-aspartate (NMDA) antagonist-induced darting behaviour by the peptidomimetic PAMTA.
Brain research 1995;682(1-2):41-9.
1994: Baures P W; Ojala W H; Gleason W B; Mishra R K; Johnson R L
Design, synthesis, X-ray analysis, and dopamine receptor-modulating activity of mimics of the "C5" hydrogen-bonded conformation in the peptidomimetic 2-oxo-3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-1- pyrrolidineacetamide.
Journal of medicinal chemistry 1994;37(22):3677-83.
1994: Morency M A; Quirion R; Mishra R K
Distribution of cholecystokinin receptors in the bovine brain: a quantitative autoradiographic study.
Neuroscience 1994;62(1):307-16.
1994: Marcotte E R; Sullivan R M; Mishra R K
Striatal G-proteins: effects of unilateral 6-hydroxydopamine lesions.
Neuroscience letters 1994;169(1-2):195-8.
1993: Genin M J; Mishra R K; Johnson R L
Dopamine receptor modulation by a highly rigid spiro bicyclic peptidomimetic of Pro-Leu-Gly-NH2.
Journal of medicinal chemistry 1993;36(22):3481-3.
1993: Subasinghe N L; Bontems R J; McIntee E; Mishra R K; Johnson R L
Bicyclic thiazolidine lactam peptidomimetics of the dopamine receptor modulating peptide Pro-Leu-Gly-NH2.
Journal of medicinal chemistry 1993;36(16):2356-61.
1993: Mamelak M; Chiu S; Mishra R K
High- and low-affinity states of dopamine D1 receptors in schizophrenia.
European journal of pharmacology 1993;233(1):175-6.
1993: Sreenivasan U; Mishra R K; Johnson R L
Synthesis and dopamine receptor modulating activity of lactam conformationally constrained analogues of Pro-Leu-Gly-NH2.
Journal of medicinal chemistry 1993;36(2):256-63.
1993: Ross G M; McCarry B E; Thakur S; Mishra R K
Identification of novel catecholamine absorbing proteins in the central nervous system.
Journal of molecular neuroscience : MN 1993;4(3):141-8.
1993: Gupta S K; Mishra R K
Desensitization of D1 dopamine receptors down-regulates the Gs alpha subunit of G protein in SK-N-MC neuroblastoma cells.
Journal of molecular neuroscience : MN 1993;4(2):117-23.
1992: Kazmi S M; Srivastava L K; Mishra R K
Functional modifications of the coupling of solubilized dopamine D2 receptors to guanine-nucleotide-binding proteins.
Biological signals 1992;1(4):194-207.
1992: Srivastava L K; Morency M A; Mishra R K
Ontogeny of dopamine D2 receptor mRNA in rat brain.
European journal of pharmacology 1992;225(2):143-50.
1992: Gupta S K; Mishra R K
Effects of chronic treatment of haloperidol and clozapine on levels of G-protein subunits in rat striatum.
Journal of molecular neuroscience : MN 1992;3(4):197-201.
1991: Morency M A; Quirion R; Nair N P; Mishra R K
Localization of cholecystokinin binding sites in canine brain using quantitative autoradiography.
Progress in neuro-psychopharmacology & biological psychiatry 1991;15(2):291-6.
1990: Gupta S K; Mishra R K
The effect of dopamine D1 and D2 receptor agonists on inositol phosphate turnover in rat striatal slices.
Biochemistry international 1990;22(5):887-94.
1990: Srivastava L K; Ross G M; Bajwa S B; Mishra R K
Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
Neurochemical research 1990;15(6):647-57.
1990: Johnson R L; Bontems R J; Yang K E; Mishra R K
Synthesis and biological evaluation of analogues of Pro-Leu-Gly-NH2 modified at the leucyl residue.
Journal of medicinal chemistry 1990;33(6):1828-32.
1990: Srivastava L K; Mishra R K
Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors.
Biochemistry international 1990;21(4):705-14.
1990: Mishra R K; Srivastava L K; Johnson R L
Modulation of high-affinity CNS dopamine D2 receptor by L-pro-L-leu-glycinamide (PLG) analogue 3(R)-(N-L-prolylamino)-2-oxo-1-pyrrolidineacetamide.
Progress in neuro-psychopharmacology & biological psychiatry 1990;14(5):821-7.
1990: Srivastava L K; Morency M A; Bajwa S B; Mishra R K
Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain.
Journal of molecular neuroscience : MN 1990;2(3):155-61.
1989: Kazmi S M; Mishra R K
Identification of alpha 2-adrenergic receptor sites in human retinoblastoma (Y-79) and neuroblastoma (SH-SY5Y) cells.
Biochemical and biophysical research communications 1989;158(3):921-8.
1988: Yu K L; Rajakumar G; Srivastava L K; Mishra R K; Johnson R L
Dopamine receptor modulation by conformationally constrained analogues of Pro-Leu-Gly-NH2.
Journal of medicinal chemistry 1988;31(7):1430-6.
1988: Srivastava L K; Bajwa S B; Johnson R L; Mishra R K
Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
Journal of neurochemistry 1988;50(3):960-8.
1988: Morency M A; Ross G M; Kajiura J S; Mishra R K
Sulfated cholecystokinin octapeptide (CCK8) failed to modulate basal or dopamine-stimulated adenylate cyclase activity in the rat striatum.
Progress in neuro-psychopharmacology & biological psychiatry 1988;12(2-3):331-6.
1987: Morency M A; Ross G M; Hesketh D; Mishra R K
Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats.
Peptides 1987;8(6):989-95.
1987: Rajakumar G; Chiu P; Chiu S; Johnson R L; Mishra R K
17 beta Estradiol-induced increase in brain dopamine D-2 receptor: antagonism by MIF-1.
Peptides 1987;8(6):997-1002.
1987: Rajakumar G; Naas F; Johnson R L; Chiu S; Yu K L; Mishra R K
Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).
Peptides 1987;8(5):855-61.
1987: Srivastava L K; Kazmi S M; Blume A J; Mishra R K
Reconstitution of affinity-purified dopamine D2 receptor binding activities by specific lipids.
Biochimica et biophysica acta 1987;900(2):175-82.
1986: Rajakumar G; Singh A N; Naas F; Chiu S; Kwan C Y; Johnson R L; Mishra R K
L-prolyl-L-leucyl-glycinamide analogues--a new class of peptide antihypertensives.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1986;4(5):S106-8.
1986: Kazmi S M; Ramwani J; Srivastava L K; Rajakumar G; Ross G M; Cullen M; Mishra R K
Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
Journal of neurochemistry 1986;47(5):1493-502.
1986: Johnson R L; Rajakumar G; Yu K L; Mishra R K
Synthesis of Pro-Leu-Gly-NH2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN.
Journal of medicinal chemistry 1986;29(10):2104-7.
1985: Chiu P; Rajakumar G; Chiu S; Johnson R L; Mishra R K
Mesolimbic and striatal dopamine receptor supersensitivity: prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG).
Peptides 1985;6(2):179-83.
1985: Ross G M; Bajwa S; Mishra R K
Factors affecting solubilization of the D1 receptor from bovine caudate nucleus.
Progress in neuro-psychopharmacology & biological psychiatry 1985;9(5-6):749-53.
1984: Chiu P; Rajakumar G; Chiu S; Kwan C Y; Mishra R K
Differential changes in central serotonin and dopamine receptors in spontaneous hypertensive rats.
Progress in neuro-psychopharmacology & biological psychiatry 1984;8(4-6):665-8.
1983: Chiu S; Wong Y W; Ferris J A; Johnson R L; Mishra R K
Binding studies of L-prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brain.
Pharmacological research communications 1983;15(1):41-51.
1983: Chiu S; Wong Y W; Wan Y P; Chiu P; Mishra R K
Are the pharmacological effects of L-prolyl-L-leucyl-glycinamide (PLG) mediated through specific receptor mechanisms?
Progress in neuro-psychopharmacology & biological psychiatry 1983;7(4-6):739-42.
1983: Mishra R K; Chiu S; Chiu P; Mishra C P
Pharmacology of L-prolyl-L-leucyl-glycinamide (PLG): a review.
Methods and findings in experimental and clinical pharmacology 1983;5(4):203-33.
1982: Chiu P; Rajakumar G; Chiu S; Kwan C Y; Mishra R K
Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR).
European journal of pharmacology 1982;82(3-4):243-4.
1982: Chiu S; Ferris J A; Johnson R; Mishra R K
CNS putative L-prolyl-L-leucyl-glycinamide (PLG) receptors, brain and lymphocyte dopamine receptors.
Progress in neuro-psychopharmacology & biological psychiatry 1982;6(4-6):365-8.

Sign-in to see more